Market Cap 23.13B
Revenue (ttm) 1.70B
Net Income (ttm) -190.43M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -11.22%
Debt to Equity Ratio 0.06
Volume 795,400
Avg Vol 1,303,516
Day's Range N/A - N/A
Shares Out 137.25M
Stochastic %K 61%
Beta 1.68
Analysts Strong Sell
Price Target $205.10

Company Profile

Natera, Inc., a diagnostics company, provides molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders; Spectrum, preimplantation genetic tests for couples und...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 650 980 9190
Address:
13011 McCallen Pass, Building A Suite 100, Austin, United States
GoldenTraderPro
GoldenTraderPro Sep. 16 at 5:52 AM
$NTRA Earnings variability expected; long-term thesis hinges on scale
0 · Reply
PMartinez1
PMartinez1 Sep. 12 at 7:13 PM
$NTRA loaded on puts over the last week. Cross my fingers.
0 · Reply
THE_Monkey_Banana_Genius
THE_Monkey_Banana_Genius Sep. 12 at 7:08 PM
$ASTS $GH $NTRA $RKLB $TTWO not too shabby
5 · Reply
justiceforb_85
justiceforb_85 Sep. 9 at 5:27 PM
$NTRA congressman buying. Will be adding more. https://www.quiverquant.com/congresstrading/trade/House-G000583-3456
0 · Reply
THE_Monkey_Banana_Genius
THE_Monkey_Banana_Genius Sep. 9 at 5:24 PM
$NTRA beautiful. Long
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 9 at 9:02 AM
$NTRA Really good write-up that perfectly summarizes NTRA's present situation. So if you want to bring your NTRA knowledge up to date or just discover NTRA, this is required reading. https://beyondspx.com/quote/NTRA/analysis/natera-momentum-builds-as-signatera-fuels-growth-and-path-to-profitability-ntra
0 · Reply
StageAnalysis
StageAnalysis Sep. 8 at 11:48 PM
Stage Analysis Screener – Inside Week <5% to the Stage 2 Level $FUL, LPX, $FND, STLD, ONB, MTB, $LIN, STEP, CVLT, STWD, GSK, GFF, FHB, SYK, $NTRA, GGG, H, SON, DPZ, MUR Filters: % to Stage Change: <5% to Stage 2 Inside Bar: True SATA Score: Strong Market Cap: +Mini (over $300MLN) WCR: Close in Upper Half of Bar Avg $ Volume: Over 100M 10W MA: Above 10 WMA 30W MA: Above 30 WMA 40W MA: Above 40 WMA Type: Stocks Sort order: Distance to Stage 2 Level The purpose of this scan is to find stocks consolidating just under their next potential Stage 2 level with strong technical attributes.
0 · Reply
Thelonius_Stonk
Thelonius_Stonk Sep. 7 at 10:57 AM
$NTRA looks so good here consolidating above '21 highs
0 · Reply
inspector_gadget86
inspector_gadget86 Aug. 29 at 11:29 PM
$NTRA yoy growth of 30 percent and tutes love this baby
0 · Reply
inspector_gadget86
inspector_gadget86 Aug. 29 at 11:25 PM
$NEO NeoGenomics said it received a favorable ruling in a patent lawsuit against Natera. $NTRA
0 · Reply
Latest News on NTRA
Can Natera Stock Reach $500?

Sep 15, 2025, 10:10 AM EDT - 1 day ago

Can Natera Stock Reach $500?


Natera Provides Update on Patent Litigation with NeoGenomics

Aug 29, 2025, 8:18 AM EDT - 18 days ago

Natera Provides Update on Patent Litigation with NeoGenomics


Natera, Inc. (NTRA) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 10:43 PM EDT - 5 weeks ago

Natera, Inc. (NTRA) Q2 2025 Earnings Call Transcript


Natera Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:05 PM EDT - 5 weeks ago

Natera Reports Second Quarter 2025 Financial Results


Natera to Report Its Second Quarter Results on August 7, 2025

Jul 31, 2025, 7:00 AM EDT - 6 weeks ago

Natera to Report Its Second Quarter Results on August 7, 2025


Natera Announces Medicare Coverage for Signatera™ Genome

Jun 4, 2025, 7:00 AM EDT - 3 months ago

Natera Announces Medicare Coverage for Signatera™ Genome


Natera: The Clues In Q1 Earnings

May 16, 2025, 8:41 AM EDT - 4 months ago

Natera: The Clues In Q1 Earnings


Natera, Inc. (NTRA) Q1 2025 Earnings Call Transcript

May 8, 2025, 8:58 PM EDT - 4 months ago

Natera, Inc. (NTRA) Q1 2025 Earnings Call Transcript


Natera Reports First Quarter 2025 Financial Results

May 8, 2025, 4:05 PM EDT - 4 months ago

Natera Reports First Quarter 2025 Financial Results


Natera to Report its First Quarter Results on May 8, 2025

May 1, 2025, 7:00 AM EDT - 4 months ago

Natera to Report its First Quarter Results on May 8, 2025


Natera, Inc. (NTRA) Q4 2024 Earnings Call Transcript

Feb 28, 2025, 12:23 AM EST - 7 months ago

Natera, Inc. (NTRA) Q4 2024 Earnings Call Transcript


Natera to Present New Data at the 2025 ASCO GI Symposium

Jan 21, 2025, 6:05 PM EST - 8 months ago

Natera to Present New Data at the 2025 ASCO GI Symposium


GoldenTraderPro
GoldenTraderPro Sep. 16 at 5:52 AM
$NTRA Earnings variability expected; long-term thesis hinges on scale
0 · Reply
PMartinez1
PMartinez1 Sep. 12 at 7:13 PM
$NTRA loaded on puts over the last week. Cross my fingers.
0 · Reply
THE_Monkey_Banana_Genius
THE_Monkey_Banana_Genius Sep. 12 at 7:08 PM
$ASTS $GH $NTRA $RKLB $TTWO not too shabby
5 · Reply
justiceforb_85
justiceforb_85 Sep. 9 at 5:27 PM
$NTRA congressman buying. Will be adding more. https://www.quiverquant.com/congresstrading/trade/House-G000583-3456
0 · Reply
THE_Monkey_Banana_Genius
THE_Monkey_Banana_Genius Sep. 9 at 5:24 PM
$NTRA beautiful. Long
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 9 at 9:02 AM
$NTRA Really good write-up that perfectly summarizes NTRA's present situation. So if you want to bring your NTRA knowledge up to date or just discover NTRA, this is required reading. https://beyondspx.com/quote/NTRA/analysis/natera-momentum-builds-as-signatera-fuels-growth-and-path-to-profitability-ntra
0 · Reply
StageAnalysis
StageAnalysis Sep. 8 at 11:48 PM
Stage Analysis Screener – Inside Week <5% to the Stage 2 Level $FUL, LPX, $FND, STLD, ONB, MTB, $LIN, STEP, CVLT, STWD, GSK, GFF, FHB, SYK, $NTRA, GGG, H, SON, DPZ, MUR Filters: % to Stage Change: <5% to Stage 2 Inside Bar: True SATA Score: Strong Market Cap: +Mini (over $300MLN) WCR: Close in Upper Half of Bar Avg $ Volume: Over 100M 10W MA: Above 10 WMA 30W MA: Above 30 WMA 40W MA: Above 40 WMA Type: Stocks Sort order: Distance to Stage 2 Level The purpose of this scan is to find stocks consolidating just under their next potential Stage 2 level with strong technical attributes.
0 · Reply
Thelonius_Stonk
Thelonius_Stonk Sep. 7 at 10:57 AM
$NTRA looks so good here consolidating above '21 highs
0 · Reply
inspector_gadget86
inspector_gadget86 Aug. 29 at 11:29 PM
$NTRA yoy growth of 30 percent and tutes love this baby
0 · Reply
inspector_gadget86
inspector_gadget86 Aug. 29 at 11:25 PM
$NEO NeoGenomics said it received a favorable ruling in a patent lawsuit against Natera. $NTRA
0 · Reply
OpenOutcrier
OpenOutcrier Aug. 29 at 12:38 PM
$NTRA (-3.2% pre) Natera loses patent ruling in $NEO NeoGenomics litigation https://ooc.bz/l/75667
0 · Reply
DonCorleone77
DonCorleone77 Aug. 29 at 11:16 AM
$NEO $NTRA NeoGenomics announces court ruling in its favor in lawsuit against Natera
0 · Reply
JudithJohnson203
JudithJohnson203 Aug. 25 at 6:22 PM
$NTRA Diagnostics leader, continuation if it holds the breakout base
0 · Reply
ZacksResearch
ZacksResearch Aug. 25 at 5:40 PM
$NTRA unveils AI platform — game-changer for precision oncology? 🚀 Natera's proprietary AI foundation integrates massive datasets to enhance drug development and clinical decision-making. Shares up 2.3% post-announcement, with a 4.6% YTD gain compared to industry's 0.9%. Discover the full impact here 👉 https://www.zacks.com/stock/news/2742434/natera-shares-rise-on-the-launch-of-ai-platform-for-precision-oncology?cid=sm-stocktwits-2-2742434-body-9397&ADID=SYND_STOCKTWITS_TWEET_2_2742434_BODY_9397
0 · Reply
ZacksResearch
ZacksResearch Aug. 25 at 4:40 PM
$NTRA popping on AI-fueled cancer care 🚀 Shares are climbing as the company rolls out its own AI platform, powered by massive oncology datasets to push precision oncology forward. See what’s driving the momentum here 👉 https://www.zacks.com/stock/news/2742434/natera-shares-rise-on-the-launch-of-ai-platform-for-precision-oncology?cid=sm-stocktwits-2-2742434-teaser-9396&ADID=SYND_STOCKTWITS_TWEET_2_2742434_TEASER_9396
0 · Reply
CaptainAmrica
CaptainAmrica Aug. 23 at 5:56 PM
$NTRA. Still working....and Holding.
0 · Reply
JasonCO
JasonCO Aug. 22 at 8:18 PM
$NTRA beast is back
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Aug. 22 at 10:20 AM
WATCHLIST AUG 22 2025 $NTRA Natera Launches Proprietary AI Foundation Models Built On 250,000+ Tumor Exomes And 1M+ Plasma Timepoints To Advance Oncology Diagnostics And Therapeutics $FFAI Faraday X Announces FX Super One Multi Purpose Vehicle Successfully Completes First Federal Motor Vehicle Safety Standards Development Tests $QTRX Quanterix Accelerator Laboratory Receives New York State Clinical Laboratory Permit; Permit Approval Enables Expanded Research Capabilities And Underscores Commitment To Accuracy, Reliability, And Scientific Excellence $ROST Ross Stores shares are trading higher after the company reported better-than-expected Q2 EPS results and issued Q4 GAAP EPS guidance above estimates. $AMBO Ambow Education Launches HybriU Events To Power Immersive, AI-Driven Interactive Live Experiences With Global Multi-Language Accessibility
0 · Reply
StockElementCorporation
StockElementCorporation Aug. 21 at 2:38 PM
$NTRA - Up +2.6% today
0 · Reply
StockElementCorporation
StockElementCorporation Aug. 20 at 6:59 PM
$NTRA - Bullish call flow
0 · Reply
vwapsmash_
vwapsmash_ Aug. 18 at 4:21 PM
$NTRA Natera's genetic testing gains traction though reimbursement challenges remain.
0 · Reply
BigSqueezeComing
BigSqueezeComing Aug. 18 at 10:56 AM
$NTRA loaded
0 · Reply